Developer docs
API playgroundTry for free, no card

Search company profiles

Genomic Diagnostics

Full company profile

uuid004hfm4

Namestring
Genomic Diagnostics
Legal namestring
Healius Pathology Pty Ltd
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Genomic Diagnostics is an Australian genetic testing provider operating as a trading brand of Healius Pathology Pty Ltd, a wholly-owned subsidiary of Healius Ltd (ASX: HLS). Founded in 1992 and headquartered in Sydney with a laboratory in Heidelberg (Melbourne), the company offers a portfolio of non-invasive and invasive genetic tests across four clinical categories: reproductive health (NIPT, expanded carrier screening via Natera, fetal Rhesus D), oncology (a family of BRAoVO™ hereditary cancer panels plus solid tumour panels for thyroid, breast, gastrointestinal stromal tumours, and melanocytic lesions), pharmacogenomics (PGx Kit and PGx Collect covering 100+ medications), and cardiology (familial hypercholesterolaemia testing).

The company's core technology layer combines proprietary test menus (notably the BRAoVO™ panel brand) with third-party assay technology (Natera Horizon carrier screen) and AI-assisted pathologist interpretation. Sample collection is delivered through the Healius Pathology network of 2,000+ collection centres across Australia, supplemented by kit-based self-collection for selected tests. Integration with Australia's My Health Record is enabled for clinician-ordered tests, while self-referred purchases bypass this upload.

The business model is a hybrid direct-to-consumer and clinician-referred model. Tests are sold as one-time fee-per-test units priced from A$127.85 (Fetal Rhesus D) to A$1,299 (BRAoVO HBOC Specialist), with payment required via the e-commerce portal before testing. Patients can self-refer for certain tests (e.g., PGx) or be referred by a GP or specialist. A bundled telehealth offering with MedMate extends the PGx product into a fully integrated clinical service. Revenue is not separately disclosed; the business operates inside Healius Pathology's broader pathology operations.

Short descriptiontext

Genomic Diagnostics is an Australian genetic testing provider offering reproductive, oncology, pharmacogenomics, and cardiology tests to patients and clinicians via a 2,000+ collection centre network and direct-to-consumer e-commerce, operating within Healius Pathology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genetic diagnostic testing, hereditary cancer panels, prenatal genetic screening, pharmacogenomics testing, carrier screening services
Industry4 codes
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Clinical Genetic Diagnostic Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Genetic Testing Services
TypeOne Time License
Description

One-time fee per genetic test performed. Tests are purchased via the e-commerce portal (pay.genomicdiagnostics.com.au) with payment required before processing. Fees are non-refundable once sample has been collected or testing has commenced. The company operates through the Healius Pathology collection network across 2,000+ locations nationally.

genomicdiagnostics.com.au
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details14 tiers
1Fetal Rhesus D Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$127.85 (price listed for non-Medicare patients)

pay.genomicdiagnostics.com.au
2BRAoVO™ Pan Cancer Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$950.00

pay.genomicdiagnostics.com.au
3BRAoVO™ Extended Gene Panel
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$650.00

pay.genomicdiagnostics.com.au
4Thyroid Cancer Panel Test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$425.00 - $799.00

pay.genomicdiagnostics.com.au
5Solid Tumour Panel Tests (Breast, GIST, Melanocytic)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Test-specific pricing; Breast Cancer Panel, GIST Panel, Expanded Melanocytic Tumour Panel listed without publicly disclosed prices

pay.genomicdiagnostics.com.au
6BRAoVO™ Plus Gene Panel
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$575.00

pay.genomicdiagnostics.com.au
7BRAoVO™ HBOC Specialist
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,299.00

pay.genomicdiagnostics.com.au
8BRAoVO™ Rare Tumour Panels (Skin & Nerve, Kidney & Endocrine, Soft Tissue & Brain)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$499.00 each (Skin & Nerve, Kidney & Endocrine, Soft Tissue & Brain Tumours)

pay.genomicdiagnostics.com.au
9BRAoVO™ ICC Specialist
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$499.00 - $575.00

pay.genomicdiagnostics.com.au
10BRAoVO™ Single Gene
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$340.00

pay.genomicdiagnostics.com.au
11Natera Horizon Expanded Carrier Screen - Individual
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$699.00 - $1,049.00 (individual test)

pay.genomicdiagnostics.com.au
12Natera Horizon Expanded Carrier Screen - Couple's
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$1,350.00 (couple's test)

pay.genomicdiagnostics.com.au
13PGx Kit (Pharmacogenomics)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$197.00 (PGx Kit - self-collected)

pay.genomicdiagnostics.com.au
14PGx Collect (Pharmacogenomics at collection centre)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Available but price not publicly disclosed on the source page

pay.genomicdiagnostics.com.au
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Genomic Diagnostics is a clinical genetic testing laboratory that performs and sells consumer- and clinician-ordered genetic tests across reproductive health (NIPT, carrier screening, fetal Rhesus D screening), hereditary and somatic oncology (the proprietary BRAoVO™ hereditary cancer panel line plus solid tumour mutation panels), pharmacogenomics (PGx Kit and PGx Collect), and cardiology (familial hypercholesterolaemia testing). Tests are processed in its NATA-accredited laboratory, interpreted by specialist pathologists, and accessed either directly by patients via its e-commerce portal or through GP/specialist referrals across the Healius Pathology collection network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 600 genetic conditions screened via Natera Horizon Expanded Carrier Screen
+1 more record
Product overview1 text field

Genomic Diagnostics is an Australian genetic testing company offering a comprehensive portfolio of genetic diagnostic tests across multiple categories. The core offerings include reproductive health tests (NIPT, Genetic Carrier Screening, Fetal Rhesus D Screening), oncology testing (Hereditary Breast and Ovarian Cancer, Colorectal Cancer Syndromes, Pancreatic and Prostate Cancer, Comprehensive and Rare Tumour Cancer Panels, and Solid Tumour Testing including Thyroid, Breast, GIST, Melanocytic, and other specific panels), pharmacogenomics testing (PGx), and cardiology testing. The company operates through the Healius Pathology network with over 2,000 collection centres nationwide. Products are sold through both clinical referral (for healthcare providers) and direct-to-consumer e-commerce platforms. Notable branded sub-products include the BRAoVO™ series of hereditary cancer panels (Pan Cancer, Extended Gene, HBOC, ICC, and organ-specific panels) and the Natera Horizon Expanded Carrier Screen.

Product and service10 records
1NIPT (Non-Invasive Prenatal Testing)
CategoryReproductive health / prenatal diagnostics
Description

A safe maternal blood test that screens for chromosomal changes in a fetus without risk to the pregnancy, providing early, accurate information. Ordered by clinicians or self-referred and processed in the Genomic Diagnostics laboratory.

2Genetic Carrier Screening
CategoryReproductive health / carrier screening
Description

Screening for carriers of common and rare genetic conditions to help inform family planning decisions, offered as individual or couple's testing via the Natera Horizon Expanded Carrier Screen covering over 600 genetic conditions.

3Fetal Rhesus D Test
CategoryReproductive health / pregnancy management
Description

Detection of fetal RHD gene fragments in maternal blood to predict fetal RhD status and guide decisions about prophylactic anti-D injections during pregnancy.

4Hereditary Breast and Ovarian Cancer (HBOC) Testing
CategoryOncology / hereditary cancer testing
Description

Detects inherited genetic changes (including BRCA1/BRCA2) that significantly increase the risk of developing breast, ovarian, and related cancers, helping to guide personalised screening and prevention.

5Inherited Colorectal Cancer Syndromes Testing
CategoryOncology / hereditary cancer testing
Description

Detects inherited genetic changes linked to 5–10% of colorectal cancers (including Lynch and polyposis syndromes), to guide screening and preventive care.

6Comprehensive Hereditary Cancer Panel Testing
CategoryOncology / hereditary cancer panel testing
Description

A broader genetic panel approach to understanding inherited cancer risk across multiple cancer types, implemented via the BRAoVO™ Pan Cancer Test and related panels.

7Rare Tumour Hereditary Cancer Panel Testing
CategoryOncology / hereditary cancer panel testing
Description

Targeted genetic panels (skin and nerve; kidney and endocrine; soft tissue and brain) to identify inherited genes that increase the risk of rare tumours and guide personalised care decisions.

8Solid Tumour Panel Tests
CategoryOncology / somatic solid tumour testing
Description

Genetic panel testing for somatic mutations in solid tumours including thyroid, breast, gastrointestinal stromal tumours (GIST), and melanocytic tumours, supporting personalised oncology treatment decisions.

9Pharmacogenomics (PGx) Testing
CategoryPharmacogenomics / precision medicine
Description

DNA testing to determine how quickly or slowly a patient metabolises over 100 medications — particularly mental health medications (antidepressants), opioids, NSAIDs, statins, and proton pump inhibitors — helping clinicians prescribe the right medication and dose the first time.

10Cardiology Genetic Testing
CategoryCardiology / inherited cardiovascular testing
Description

Genetic testing to support the diagnosis and management of familial hypercholesterolaemia (FH) and other cardiology risks, enabling personalised cardiology care.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MedMate provides telehealth GP consultations as part of the PGx plus Telehealth bundle offered by Genomic Diagnostics. Genomic Diagnostics provides the PGx Home Swab Kit while MedMate clinicians provide two telehealth consultations and determine clinical appropriateness for the test referral. Test results are shared with MedMate clinicians for interpretation and follow-up care management.

Strategic tierCoreTypeOthers
Description

Genomic Diagnostics is a trading name of Healius Pathology Pty Ltd. The company operates within the Healius Pathology network, which includes multiple pathology brands across Australia: Laverty Pathology (NSW/ACT), Dorevitch Pathology (VIC), QML Pathology (QLD), Abbott Pathology (SA), Western Diagnostic Pathology (WA/NT), and TML Pathology (TAS). The Genomic Diagnostics logo is a registered trademark of Healius Pathology Pty Ltd.

Strategic tierCoreTypeTechnology or Integration
Description

Natera provides the Horizon Expanded Carrier Screen tests used by Genomic Diagnostics for expanded carrier screening. The Horizon screen covers over 600 genetic conditions and is available as individual or couple's testing. Genomic Diagnostics offers these tests through its e-commerce platform.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genomic Diagnostics

Clinical Genetic Diagnostic Servicesgenomicdiagnostics.com.au

Genomic Diagnostics is an Australian genetic testing provider offering reproductive, oncology, pharmacogenomics, and cardiology tests to patients and clinicians via a 2,000+ collection centre network and direct-to-consumer e-commerce, operating within Healius Pathology.

What Genomic Diagnostics does

Genomic Diagnostics is an Australian genetic testing provider operating as a trading brand of Healius Pathology Pty Ltd, a wholly-owned subsidiary of Healius Ltd (ASX: HLS). Founded in 1992 and headquartered in Sydney with a laboratory in Heidelberg (Melbourne), the company offers a portfolio of non-invasive and invasive genetic tests across four clinical categories: reproductive health (NIPT, expanded carrier screening via Natera, fetal Rhesus D), oncology (a family of BRAoVO™ hereditary cancer panels plus solid tumour panels for thyroid, breast, gastrointestinal stromal tumours, and melanocytic lesions), pharmacogenomics (PGx Kit and PGx Collect covering 100+ medications), and cardiology (familial hypercholesterolaemia testing).

The company's core technology layer combines proprietary test menus (notably the BRAoVO™ panel brand) with third-party assay technology (Natera Horizon carrier screen) and AI-assisted pathologist interpretation. Sample collection is delivered through the Healius Pathology network of 2,000+ collection centres across Australia, supplemented by kit-based self-collection for selected tests. Integration with Australia's My Health Record is enabled for clinician-ordered tests, while self-referred purchases bypass this upload.

The business model is a hybrid direct-to-consumer and clinician-referred model. Tests are sold as one-time fee-per-test units priced from A$127.85 (Fetal Rhesus D) to A$1,299 (BRAoVO HBOC Specialist), with payment required via the e-commerce portal before testing. Patients can self-refer for certain tests (e.g., PGx) or be referred by a GP or specialist. A bundled telehealth offering with MedMate extends the PGx product into a fully integrated clinical service. Revenue is not separately disclosed; the business operates inside Healius Pathology's broader pathology operations.

Genomic Diagnostics firmographics

Firmographics
Name
Genomic Diagnostics
Legal name
Healius Pathology Pty Ltd
Website
https://genomicdiagnostics.com.au
Company type
Private
Operating status
Operating
Headcount range
51–100 employees
Short description
Genomic Diagnostics is an Australian genetic testing provider offering reproductive, oncology, pharmacogenomics, and cardiology tests to patients and clinicians via a 2,000+ collection centre network and direct-to-consumer e-commerce, operating within Healius Pathology.
Ownership category
akta.pro rank

Genomic Diagnostics industry classification

Industry
Product category
Clinical Genetic Diagnostic Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Genetic diagnostic testing
  • Hereditary cancer panels
  • Prenatal genetic screening
  • Pharmacogenomics testing
  • Carrier screening services

Where Genomic Diagnostics is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices3 records

Markets served

Genomic Diagnostics business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Genetic Testing Services: One-time fee per genetic test performed. Tests are purchased via the e-commerce portal (pay.genomicdiagnostics.com.au) with payment required before processing. Fees are non-refundable once sample has been collected or testing has commenced. The company operates through the Healius Pathology collection network across 2,000+ locations nationally.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goFetal Rhesus D Test
Unit PricingPay-as-you-goBRAoVO™ Pan Cancer Test
Unit PricingPay-as-you-goBRAoVO™ Extended Gene Panel
Unit PricingPay-as-you-goThyroid Cancer Panel Test
Unit PricingPay-as-you-goSolid Tumour Panel Tests (Breast, GIST, Melanocytic)
Unit PricingPay-as-you-goBRAoVO™ Plus Gene Panel
Unit PricingPay-as-you-goBRAoVO™ HBOC Specialist
Unit PricingPay-as-you-goBRAoVO™ Rare Tumour Panels (Skin & Nerve, Kidney & Endocrine, Soft Tissue & Brain)
Unit PricingPay-as-you-goBRAoVO™ ICC Specialist
Unit PricingPay-as-you-goBRAoVO™ Single Gene
Unit PricingPay-as-you-goNatera Horizon Expanded Carrier Screen - Individual
Unit PricingPay-as-you-goNatera Horizon Expanded Carrier Screen - Couple's
Unit PricingPay-as-you-goPGx Kit (Pharmacogenomics)
Unit PricingPay-as-you-goPGx Collect (Pharmacogenomics at collection centre)

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Genomic Diagnostics product offering

Product offering

Core offering

Genomic Diagnostics is a clinical genetic testing laboratory that performs and sells consumer- and clinician-ordered genetic tests across reproductive health (NIPT, carrier screening, fetal Rhesus D screening), hereditary and somatic oncology (the proprietary BRAoVO™ hereditary cancer panel line plus solid tumour mutation panels), pharmacogenomics (PGx Kit and PGx Collect), and cardiology (familial hypercholesterolaemia testing). Tests are processed in its NATA-accredited laboratory, interpreted by specialist pathologists, and accessed either directly by patients via its e-commerce portal or through GP/specialist referrals across the Healius Pathology collection network.

Product overview

Genomic Diagnostics is an Australian genetic testing company offering a comprehensive portfolio of genetic diagnostic tests across multiple categories. The core offerings include reproductive health tests (NIPT, Genetic Carrier Screening, Fetal Rhesus D Screening), oncology testing (Hereditary Breast and Ovarian Cancer, Colorectal Cancer Syndromes, Pancreatic and Prostate Cancer, Comprehensive and Rare Tumour Cancer Panels, and Solid Tumour Testing including Thyroid, Breast, GIST, Melanocytic, and other specific panels), pharmacogenomics testing (PGx), and cardiology testing. The company operates through the Healius Pathology network with over 2,000 collection centres nationwide. Products are sold through both clinical referral (for healthcare providers) and direct-to-consumer e-commerce platforms. Notable branded sub-products include the BRAoVO™ series of hereditary cancer panels (Pan Cancer, Extended Gene, HBOC, ICC, and organ-specific panels) and the Natera Horizon Expanded Carrier Screen.

Differentiator

Problem solved

Functional benefit

Products and services

  • NIPT (Non-Invasive Prenatal Testing) A safe maternal blood test that screens for chromosomal changes in a fetus without risk to the pregnancy, providing early, accurate information. Ordered by clinicians or self-referred and processed in the Genomic Diagnostics laboratory.
  • Genetic Carrier Screening Screening for carriers of common and rare genetic conditions to help inform family planning decisions, offered as individual or couple's testing via the Natera Horizon Expanded Carrier Screen covering over 600 genetic conditions.
  • Fetal Rhesus D Test Detection of fetal RHD gene fragments in maternal blood to predict fetal RhD status and guide decisions about prophylactic anti-D injections during pregnancy.
  • Hereditary Breast and Ovarian Cancer (HBOC) Testing Detects inherited genetic changes (including BRCA1/BRCA2) that significantly increase the risk of developing breast, ovarian, and related cancers, helping to guide personalised screening and prevention.
  • Inherited Colorectal Cancer Syndromes Testing Detects inherited genetic changes linked to 5–10% of colorectal cancers (including Lynch and polyposis syndromes), to guide screening and preventive care.
  • Comprehensive Hereditary Cancer Panel Testing A broader genetic panel approach to understanding inherited cancer risk across multiple cancer types, implemented via the BRAoVO™ Pan Cancer Test and related panels.
  • Rare Tumour Hereditary Cancer Panel Testing Targeted genetic panels (skin and nerve; kidney and endocrine; soft tissue and brain) to identify inherited genes that increase the risk of rare tumours and guide personalised care decisions.
  • Solid Tumour Panel Tests Genetic panel testing for somatic mutations in solid tumours including thyroid, breast, gastrointestinal stromal tumours (GIST), and melanocytic tumours, supporting personalised oncology treatment decisions.
  • Pharmacogenomics (PGx) Testing DNA testing to determine how quickly or slowly a patient metabolises over 100 medications — particularly mental health medications (antidepressants), opioids, NSAIDs, statins, and proton pump inhibitors — helping clinicians prescribe the right medication and dose the first time.
  • Cardiology Genetic Testing Genetic testing to support the diagnosis and management of familial hypercholesterolaemia (FH) and other cardiology risks, enabling personalised cardiology care.

Quantifiable outcome

  • Over 600 genetic conditions screened via Natera Horizon Expanded Carrier Screen
  • +1 more outcomes

Companies that use Genomic Diagnostics

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Genomic Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature5 records

Genomic Diagnostics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • MedMatecoreStrategic or Co-development PartnerMedMate provides telehealth GP consultations as part of the PGx plus Telehealth bundle offered by Genomic Diagnostics. Genomic Diagnostics provides the PGx Home Swab Kit while MedMate clinicians provide two telehealth consultations and determine clinical appropriateness for the test referral. Test results are shared with MedMate clinicians for interpretation and follow-up care management.
  • Healius Pathology Pty LtdcoreOthersGenomic Diagnostics is a trading name of Healius Pathology Pty Ltd. The company operates within the Healius Pathology network, which includes multiple pathology brands across Australia: Laverty Pathology (NSW/ACT), Dorevitch Pathology (VIC), QML Pathology (QLD), Abbott Pathology (SA), Western Diagnostic Pathology (WA/NT), and TML Pathology (TAS). The Genomic Diagnostics logo is a registered trademark of Healius Pathology Pty Ltd.
  • NateracoreTechnology or IntegrationNatera provides the Horizon Expanded Carrier Screen tests used by Genomic Diagnostics for expanded carrier screening. The Horizon screen covers over 600 genetic conditions and is available as individual or couple's testing. Genomic Diagnostics offers these tests through its e-commerce platform.

Scale indicators4 records

Recent moves7 records

Expansion highlights7 records

Genomic Diagnostics competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights6 records

Customer concentration

Genomic Diagnostics social profiles

Digital presence

Genomic Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genomic Diagnostics leadership team

Management profile

Number of profiles

Profiles9 records

Genomic Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genomic Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genomic Diagnostics

What does Genomic Diagnostics do?

Genomic Diagnostics is a clinical genetic testing laboratory that performs and sells consumer- and clinician-ordered genetic tests across reproductive health (NIPT, carrier screening, fetal Rhesus D screening), hereditary and somatic oncology (the proprietary BRAoVO™ hereditary cancer panel line plus solid tumour mutation panels), pharmacogenomics (PGx Kit and PGx Collect), and cardiology (familial hypercholesterolaemia testing). Tests are processed in its NATA-accredited laboratory, interpreted by specialist pathologists, and accessed either directly by patients via its e-commerce portal or through GP/specialist referrals across the Healius Pathology collection network.

Is Genomic Diagnostics a public or private company?

Genomic Diagnostics is a private company. It is classified as corporate owned and is currently operating.

When was Genomic Diagnostics founded?

Genomic Diagnostics was founded in -1. It employs 51 to 100 people.

Where is Genomic Diagnostics based?

Genomic Diagnostics is headquartered in Sydney, Australia, in the Oceania region.

How does Genomic Diagnostics make money?

One revenue line is on record: genetic Testing Services.

Does Genomic Diagnostics have an API?

No public API is recorded for Genomic Diagnostics.

What industry is Genomic Diagnostics in?

Genomic Diagnostics's product category is Clinical Genetic Diagnostic Services. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales